Kynamro Ευρωπαϊκή Ένωση - Ρουμανικά - EMA (European Medicines Agency)

kynamro

genzyme europe bv - mipomersen sodiu - hipercolesterolemia - sistemul cardiovascular - tratamentul de colesterol și hipercolesterolemie,.

Tegsedi Ευρωπαϊκή Ένωση - Ρουμανικά - EMA (European Medicines Agency)

tegsedi

akcea therapeutics ireland limited - inotersen de sodiu - amiloidoza - alte medicamente pentru sistemul nervos - tratamentul etapa 1 sau 2 polineuropatie la pacienți adulți cu afecțiuni ereditare transthyretin amiloidoza (hattr).

Triumeq Ευρωπαϊκή Ένωση - Ρουμανικά - EMA (European Medicines Agency)

triumeq

viiv healthcare b.v. - dolutegravir sodium, lamivudine, abacavir (as sulfate) - infecții cu hiv - antivirale pentru uz sistemic - triumeq is indicated for the treatment of human immunodeficiency virus (hiv) infected adults,  adolescents and children  weighing at least 25 kg who are antiretroviral treatment-naïve or are infected with hiv without documented or clinically suspected resistance to any of the three antiretroviral agents in triumeq.

Pedmarqsi Ευρωπαϊκή Ένωση - Ρουμανικά - EMA (European Medicines Agency)

pedmarqsi

fennec pharmaceuticals (eu) limited - sodium thiosulfate - ear diseases; ototoxicity - toate celelalte produse terapeutice - pedmarqsi is indicated for the prevention of ototoxicity induced by cisplatin chemotherapy in patients 1 month to < 18 years of age with localised, non-metastatic, solid tumours.